BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12426287)

  • 1. Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.
    de Serres FJ
    Chest; 2002 Nov; 122(5):1818-29. PubMed ID: 12426287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed.
    de Serres FJ
    Environ Health Perspect; 2003 Dec; 111(16):1851-4. PubMed ID: 14654440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America.
    de Serres FJ; Blanco I; Fernández-Bustillo E
    Clin Genet; 2003 Nov; 64(5):382-97. PubMed ID: 14616761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic epidemiology of alpha-1 antitrypsin deficiency in southern Europe: France, Italy, Portugal and Spain.
    de Serres FJ; Blanco I; Fernández-Bustillo E
    Clin Genet; 2003 Jun; 63(6):490-509. PubMed ID: 12786756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimates of PI*S and PI*Z Alpha-1 antitrypsin deficiency alleles prevalence in the Caribbean and North, Central and South America.
    de Serres FJ; Blanco I; Fernández-Bustillo E
    Monaldi Arch Chest Dis; 2009 Sep; 71(3):96-105. PubMed ID: 19999955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic differences in alpha-1 antitrypsin deficiency in the United States of America.
    de Serres FJ; Blanco I; Fernández-Bustillo E
    Ther Adv Respir Dis; 2010 Apr; 4(2):63-70. PubMed ID: 20435667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health implications of alpha1-antitrypsin deficiency in Sub-Sahara African countries and their emigrants in Europe and the New World.
    de Serres FJ; Blanco I; Fernández-Bustillo E
    Genet Med; 2005 Mar; 7(3):175-84. PubMed ID: 15775753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the risk for alpha-1 antitrypsin deficiency among COPD patients: evidence supporting targeted screening.
    de Serres FJ; Blanco I; Fernández-Bustillo E
    COPD; 2006 Aug; 3(3):133-9. PubMed ID: 17240615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1 antitrypsin deficiency in Italy: regional differences of the PIS and PIZ deficiency alleles.
    de Serres FJ; Luisetti M; Ferrarotti I; Blanco I; Fernández-Bustillo E
    Monaldi Arch Chest Dis; 2005 Sep; 63(3):133-41. PubMed ID: 16312203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PI*S and PI*Z alpha 1-antitrypsin deficiency: estimated prevalence and number of deficient subjects in Spain].
    Blanco I; Fernández-Bustillo E; de Serres FJ; Alkassam D; Rodríguez Menéndez C
    Med Clin (Barc); 2004 Dec; 123(20):761-5. PubMed ID: 15607066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI S and PI Z alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data.
    de Serres FJ; Blanco I; Fernández-Bustillo E
    Monaldi Arch Chest Dis; 2007 Dec; 67(4):184-208. PubMed ID: 18309698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European screening for alpha
    Greulich T; Averyanov A; Borsa L; Rozborilová E; Vaicius D; Major T; Chopyak V; Tudorache V; Konstantinova T; Camprubí S
    Clin Respir J; 2017 Jan; 11(1):90-97. PubMed ID: 25919395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated Prevalence and Number of PiMZ Genotypes of Alpha-1 Antitrypsin in Seventy-Four Countries Worldwide.
    Martinez-González C; Blanco I; Diego I; Bueno P; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2617-2630. PubMed ID: 34556982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency.
    Luisetti M; Seersholm N
    Thorax; 2004 Feb; 59(2):164-9. PubMed ID: 14760160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update.
    Blanco I; Bueno P; Diego I; Pérez-Holanda S; Casas-Maldonado F; Esquinas C; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():561-569. PubMed ID: 28243076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort.
    Thun GA; Ferrarotti I; Imboden M; Rochat T; Gerbase M; Kronenberg F; Bridevaux PO; Zemp E; Zorzetto M; Ottaviani S; Russi EW; Luisetti M; Probst-Hensch NM
    PLoS One; 2012; 7(8):e42728. PubMed ID: 22912729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the two common alpha-1-antitrypsin deficiency alleles PiMS and PiMZ as modifiers of Pseudomonas aeruginosa susceptibility in cystic fibrosis.
    Meyer P; Braun A; Roscher AA
    Clin Genet; 2002 Oct; 62(4):325-7. PubMed ID: 12372062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
    Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
    Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine protease inhibitors in patients with chronic viral hepatitis.
    Elzouki AN; Verbaan H; Lindgren S; Widell A; Carlson J; Eriksson S
    J Hepatol; 1997 Jul; 27(1):42-8. PubMed ID: 9252072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development.
    Stockley RA; Luisetti M; Miravitlles M; Piitulainen E; Fernandez P;
    Eur Respir J; 2007 Mar; 29(3):582-6. PubMed ID: 17329492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.